| Home | E-Submission | Sitemap | Contact Us |  
top_img
Journal of the Korean Neurological Association 2003;21(6): 573-583.
퇴행성 신경계 질환에서 Ubiquitin-Proteasome 경로의 역할
최경선 , 최철희
이화여자대학교 대학원 분자생명과학부
"The Role of the Ubiquitin-Proteasome Pathway in Neurodegenerative Disorders"
Kyungsun Choi
Division of Molecular Life Sciences and Center for Cell Signaling Research, Ewha Womans University, Seoul, Korea
Abstract
Impaired function of the Ubiquitin (Ub)/proteasome pathway is one of the molecular mechanisms underlying aging process and neurodegenerative disorders such as Parkinson’s Disease and Alzheimer’s Disease (AD). Among many vital cellular functions, the Ub/proteasome pathway regulates immune responses via mediating activation of NF-κB by pro-inflammatory signals. Dysfunction of this pathway may aberrantly affect the signaling of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), which are abundantly present in AD brains. To address this, chemokine expression was measured as a readout for IL-1β and TNF-α signaling in human astrocytes. Proteasome inhibitors, MG-132 and lactacystin, suppressed IL-1β and TNF-α-induced expression of MCP-1, RANTES and IP-10, but not that of IL-8. In addition, human astrocytes underwent apoptotic cell death upon treatment with IL-1β and TNF-α only in the presence of the proteasome inhibitors. These results suggest that inhibition of the Ub/proteasome pathway dysregulates pro-inflammatory cytokine signaling in human astrocytes, leading to divergent chemokine expression and enhanced cell death. Therefore, we propose that the immuno-pathologic role of astrocytes in AD brains should be re-evaluated under the circumstances of impaired function of the Ub/proteasome pathway.Key Words: Astrocytes, Neurodegenerative disorders, Neuroimmunology, Cytokines, MG-132
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
  E-Mail
Share:      
METRICS
570
View
4
Down